Table of Content

Table of Contents

1. Executive Summary

2. Global Diagnostic Radioisotope Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031
3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
3.2. Global Diagnostic Radioisotope Market Trends (2019-2024) and Forecast (2025-2031)
3.3: Global Diagnostic Radioisotope Market by Radioisotope
3.3.1: Technetium-99m
3.3.2: Thallium-201
3.3.3: Gallium-67
3.3.4: Iodine-123
3.3.5: FDG
3.3.6: Rubidium-82
3.3.7: Others
3.4: Global Diagnostic Radioisotope Market by Imaging Modality
3.4.1: SPECT
3.4.2: PET
3.4.3: Beta Emitters
3.5: Global Diagnostic Radioisotope Market by Application
3.5.1: Diagnostic
3.5.2: Therapeutic
3.6: Global Diagnostic Radioisotope Market by End Use
3.6.1: Hospitals
3.6.2: Specialty Clinics
3.6.3: Diagnostic Centers
3.6.4: Academic & Research Institutes
3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031
4.1: Global Diagnostic Radioisotope Market by Region
4.2: North American Diagnostic Radioisotope Market
4.2.1: North American Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
4.2.2: North American Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
4.3: European Diagnostic Radioisotope Market
4.3.1: European Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
4.3.2: European Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
4.4: APAC Diagnostic Radioisotope Market
4.4.1: APAC Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
4.4.2: APAC Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
4.5: ROW Diagnostic Radioisotope Market
4.5.1: ROW Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
4.5.2: ROW Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Diagnostic Radioisotope Market by Radioisotope
6.1.2: Growth Opportunities for the Global Diagnostic Radioisotope Market by Imaging Modality
6.1.3: Growth Opportunities for the Global Diagnostic Radioisotope Market by Application
6.1.4: Growth Opportunities for the Global Diagnostic Radioisotope Market by End Use
6.1.5: Growth Opportunities for the Global Diagnostic Radioisotope Market by Region
6.2: Emerging Trends in the Global Diagnostic Radioisotope Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Diagnostic Radioisotope Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Diagnostic Radioisotope Market
6.3.4: Certification and Licensing

7. Company Profiles of Leading Players
7.1: GE Healthcare
7.2: Siemens Healthineers
7.3: Koninklijke Philips
7.4: Cardinal Health
7.5: Lantheus Holdings
7.6: Bayer
7.7: Bracco
7.8: Eckert & Ziegler